LENSAR, Inc. (LNSR)

Market Cap	78.26M -45.6%
Revenue (ttm)	60.26M +3.3%
Net Income	14.70M
EPS	0.53
Shares Out	12.29M
PE Ratio	12.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,331
Open	6.43
Previous Close	6.45
Day's Range	6.37 - 6.54
52-Week Range	4.95 - 12.94
Beta	0.95
Analysts	Strong Buy
Price Target	11.33 (+77.87%)
Est. Earnings	Nov 5, 2026

About LNSR

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 150
• Stock Exchange: Nasdaq
• Ticker Symbol: LNSR
• Website: https://www.lensar.com

Financial Performance

In 2025, LENSAR's revenue was $58.44 million, an increase of 9.24% compared to the previous year's $53.49 million. Losses were -$34.28 million, 9.16% more than in 2024.

Analyst Summary

According to 3 analysts, the average rating for LNSR stock is "Strong Buy." The 12-month stock price target is $11.33, which is an increase of 77.87% from the latest price.

Price Target

$11.33

(77.87% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 10, 2026

Data Sources Report a data error